BPC-157 and TB-500 compared
Two repair peptides with different mechanisms. What each is studied for, what the evidence supports, and how handling differs.
Reference
Every compound we stock, with the analytical data and the certificate.
Every compound we stock, with the analytical data behind it and the certificate for the batch currently on the shelf.
These pages are written for people who want to know what a molecule actually is and what question the research is asking of it. Grouped by research area, because that is how most people arrive.
Two repair peptides with different mechanisms. What each is studied for, what the evidence supports, and how handling differs.
How the two differ, and why they are frequently supplied together.
Copper peptides, antioxidants and the combination preparations.
What degrades a peptide in practice, how much a freeze thaw cycle actually costs you, and how to plan aliquots so it stops mattering.
Secretagogues against releasing hormones against growth hormone itself.
Nine questions that separate a supplier running real analysis from one reselling someone else’s paperwork, and what each answer actually tells you.
A section by section walkthrough of a peptide certificate: what each figure means, what it does not mean, and the checks worth making before you accept a batch.
NAD+, Epitalon, SS-31 and MOTS-c, and what distinguishes each.
Receptor targets, dual against triple agonism, and the regulatory position.
Three related molecules routinely treated as interchangeable in discussion. How they differ and which your protocol actually needs.
A vial at 99 percent HPLC purity can be around 75 percent peptide by mass. Where the rest goes, and when the difference matters.
How every batch is tested, what the certificate of analysis shows, and how to read it.
Choosing a solvent, adding it without damaging the peptide, working out concentrations, and the handling errors that cost people a vial.
The compounds studied in tissue repair models, and how they differ.
Temperature, light, reconstitution and shelf life, and what actually degrades a compound in practice.
Dual against triple receptor agonism. What each targets, how the pharmacology differs, and where each sits regulatorily.
Dual against triple agonism, and where each sits in development.
HPLC purity, net peptide content, and why two suppliers quoting 99 percent are not necessarily selling the same thing.
The sequence, what it derives from, and the models it has been studied in.
The tetrapeptide sequence, its origin, and the two spellings.
The copper complex, and why this one is legitimately blue.
The structure, and why oxidation makes this one awkward to store.
The sequence, and what selective secretagogue means.
The sequence, and what makes a mitochondrial derived peptide different.
The structure, the cofactor role, and why it stores differently to the peptides.
The triple receptor mechanism, and how it differs from tirzepatide.
The sequence, and why elamipretide and MTP-131 are the same thing.
The fragment sequence, and the difference between TB-500 and thymosin beta-4.
Ask us about any compound in the catalogue and a real person will answer.